Lupin gains FDA approval for generic Pitavastatin Tablets, targeting $298m market

Global pharmaceutical giant Lupin Limited announced its receipt of approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ... Read More